Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
The study met its primary endpoint with no procedure or device related serious adverse events reportedRUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GCTK) (“Glucotrack” or the “Company” ...
Business Insider10d
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Goode, PhD, President & Chief Executive Officer of Glucotrack. “With these positive results, the promise of continuous blood glucose monitoring is one step closer to reality.” The prospective ...
Nasdaq10d
Glucotrack, Inc. Announces Successful Completion of First Human Clinical Study for Continuous Blood Glucose Monitoring Technology
Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real ...
Finanznachrichten10d
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Goode, PhD, President & Chief Executive Officer of Glucotrack. "With these positive results, the promise of continuous blood glucose monitoring is one step closer to reality." The prospective single ...